Wealth Enhancement Advisory Services, LLC Crispr Therapeutics Ag Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 82,607 shares of CRSP stock, worth $4.59 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
82,607
Previous 94,100
12.21%
Holding current value
$4.59 Million
Previous $3.2 Million
25.48%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CRSP
# of Institutions
489Shares Held
64.5MCall Options Held
2.16MPut Options Held
2.1M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$566 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$338 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$211 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$154 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$141 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.34B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....